INCREASED ERYTHROCYTE ALDOSE REDUCTASE-ACTIVITY IN TYPE-1 DIABETIC-PATIENTS

被引：11

作者：

HAMADA, Y ^{[1
]}

KITO, R ^{[1
]}

RASKIN, P ^{[1
]}

机构：

[1] UNIV TEXAS,SW MED CTR,DEPT INTERNAL MED,5323 HARRY HINES BLVD,DALLAS,TX 75235

来源：

DIABETIC MEDICINE | 1991年 / 8卷 / 03期

关键词：

ALDOSE REDUCTASE; ERYTHROCYTES; TYPE-1; DIABETES;

D O I：

10.1111/j.1464-5491.1991.tb01577.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Elevated erythrocyte sorbitol levels have been demonstrated in diabetic patients. In order to explain the enhanced sorbitol formation, it has been suggested that aldose reductase might be activated by hyperglycaemia. Although aldose reductase activity has been reported to be increased in some tissues of diabetic patients, the effects of varying concentrations of glucose on the enzyme activity in vivo are unknown. To determine whether or not erythrocyte aldose reductase activity is increased in diabetic patients and is affected by glucose levels, we collected blood samples from 10 Type 1 diabetic patients while fasting and 2 h after a standard meal. We measured the activity of erythrocyte aldose reductase after partial purification by column chromatography. The results showed that erythrocyte aldose reductase activity was significantly increased in diabetic patients as compared with non-diabetic subjects (7.3 +/- 0.7 (+/- SE) vs 5.2 +/- 0.3 u l-erythrocytes-1, p < 0.05). No correlation, however, was observed between fasting plasma glucose levels and the enzyme activity, and acute elevation of the blood glucose level did not affect the enzyme activity.

引用

页码：226 / 231

页数：6

共 33 条

[1] Gabbay KH, The sorbitol pathway and the complications of diabetes, N Engl J Med, 288, pp. 831-836, (1973)
[2] Kador PF, Kinoshita JH, Role of aldose reductase in the development of diabetes‐associated complications, Am J Med, 79, pp. 8-12, (1985)
[3] Kinoshita JH, Kador PF, Robison WG, Datilis MB, Cobo LM, Kupfer C., Aldose reductase and complications of diabetes, Ann Intern Med, 101, pp. 82-91, (1984)
[4] Raskin P., Rosenstock J., Aldose reductase inhibitors and diabetic complications, Am J Med, 83, pp. 298-306, (1987)
[5] Van Heyningen R., Formation of polyols by the lens of the rat with ‘sugar’ cataract, Nature, 184, pp. 194-195, (1959)
[6] Kinoshita JH, Merola LO, Satoh K., Dikmac E., Osmotic changes caused by the accumulation of dulcitol in the lenses of rats fed with galactose, Nature, 194, pp. 1085-1087, (1962)
[7] Gabbay KH, Merola LO, Field RA, Sorbitol pathway: presence in nerve and cord with substrate accumulation in diabetes, Science, 151, pp. 209-210, (1966)
[8] Beyer-Mears A., Ku L., Cohen MP, Glomerular polyol accumulation in diabetes and its prevention by oral sorbinil, Diabetes, 33, pp. 604-607, (1984)
[9] Dyck PJ, Zimmerman BR, Vilen TH, Et al., Nerve glucose, fructose, sorbitol, myoinositol, and fiber degeneration and regeneration in diabetic neuropathy, N Engl J Med, 319, pp. 542-548, (1988)
[10] Malone JI, Knox G., Harvey C., Sorbitol accumulation is altered in Type 1 (insulin dependent) diabetes mellitus, Diabetologia, 27, pp. 509-513, (1984)

← 1 2 3 4 →